Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Current Leases (2020 - 2025)

GoHealth (GOCO) has disclosed Current Leases for 6 consecutive years, with $7.2 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 25.5% to $7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, up 25.5% year-over-year, with the annual reading at $7.2 million for FY2025, 25.5% up from the prior year.
  • Current Leases hit $7.2 million in Q4 2025 for GoHealth, up from $4.9 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $10.0 million in Q2 2022 to a low of $4.6 million in Q1 2025.
  • Historically, Current Leases has averaged $6.4 million across 5 years, with a median of $5.8 million in 2023.
  • Biggest five-year swings in Current Leases: soared 46.49% in 2022 and later plummeted 38.33% in 2023.
  • Year by year, Current Leases stood at $6.1 million in 2021, then surged by 46.49% to $9.0 million in 2022, then tumbled by 35.4% to $5.8 million in 2023, then fell by 1.59% to $5.7 million in 2024, then rose by 25.5% to $7.2 million in 2025.
  • Business Quant data shows Current Leases for GOCO at $7.2 million in Q4 2025, $4.9 million in Q3 2025, and $4.8 million in Q2 2025.